Cancer Genetics Inc (NASDAQ:CGIX)

10.62
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
4.83
Today|||52-Week Range
16.88
+58.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-19.9M-6.7M-12.4M--
 
 
 
 
Depreciation369.7K353.4K326.5K--
 
 
 
 
Total Other Cash Flow13.0M-973.8K5.8M--
 
 
 
 
Funds From Operations-6.5M-7.3M-6.3M--
 
 
 
 
Funds From/For Other Operating Expenses-1.4M291.8K1.8M--
 
 
 
 
Net Cash Flow - Operating Activities-5.1M-7.6M-8.1M-12.3M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-1.0M--
 
 
Capital Expenditures-268.6K-162.5K-257.3K--
 
 
 
 
Other Investing - Uses0.00-50.0K-50.0K--
 
 
 
Other Investing - Sources238.4K0.00----
 
 
Net Cash Flow Investing-113.1K-347.8K-1.4M-11.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings6.2M7.1M0.00--
 
 
 
Long Term Debt Reduction-242.7K-54.0K-3.6M--
 
 
 
 
Net Proceeds Stock Sale-132.9K-737.8K61.7M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing5.8M6.3M58.1M-195.1K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.00----
 
Net Change In Cash638.0K-1.6M48.6M-23.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account